Literature DB >> 314638

Central antiserotonin action of amitriptyline.

J Maj, A Lewandowska, A Rawtów.   

Abstract

Amitriptyline (AMI) was studied in rats snd mice in order to find out whether it had a central antiserotonin activity, previously demonstrated for doxepin - a compound chemically related to AMI. It was observed that AMI at low doses antagonized the head twitch response to L-5-hydroxytryptophan or 5-methoxytryptamine, as well as tryptamine-induced convulsions. In the hind limb flexor reflex preparation of the spinal rat AMI acted as a serotonin antagonist: when administered alone, it did not change the flexor reflex but prevented its stimulation induced by serotoninmimetics (LSD, quipazine, fenfluramine) not affecting that one evoked by noradrenalinemimetics (clinidine). At higher doses, AMI revealed a noradrenolytic activity. The results indicate that AMI, similarly as doxepin, has a central antiserotonin activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 314638     DOI: 10.1055/s-0028-1094622

Source DB:  PubMed          Journal:  Pharmakopsychiatr Neuropsychopharmakol        ISSN: 0031-7098


  10 in total

1.  Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram.

Authors:  L Pawłowski; M Melzacka
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour.

Authors:  J F Stolz; C A Marsden; D N Middlemiss
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

3.  Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites.

Authors:  M A Blackshear; R L Friedman; E Sanders-Bush
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

4.  Chronic treatment with some atypical antidepressants increases the brain level of 3-methoxy-4-hydroxyphenylglycol (MHPG) in rats.

Authors:  E Przegaliński; A Kordecka-Magiera; E Mogilnicka; J Maj
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Is Ro 11-2465 (cyan-imipramine) an antagonist of postsynaptic serotonin receptors?

Authors:  L Pawłowski; H Kwiatek; Z Górka
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

6.  The effect of IV L-tryptophan on prolactin, growth hormone, and mood in healthy subjects.

Authors:  D S Charney; G R Heninger; J F Reinhard; D E Sternberg; K M Hafstead
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  The effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects.

Authors:  D S Charney; G R Heninger; J F Reinhard; D E Sternberg; K M Hafstead
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Comparison of the pharmacological actions of desmethylclomipramine and clomipramine.

Authors:  J Maj; L Stala; Z Górka; A Adamus
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  Citalopram: a new potent inhibitor of serotonin (5-HT) uptake with central 5-HT-mimetic properties.

Authors:  L Pawłowski; J Ruczyńska; Z Górka
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Chronic treatment with antidepressants: protentiation of clonidine-induced aggression in mice via noradrenergic mechanism.

Authors:  J Maj; E Mogilnicka; V Klimek; A Kordecka-Magiera
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.